Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 2770 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
M. Ashworth, Charlton, J., Latinovic, R., and Gulliford, M., Age-related changes in consultations and antibiotic prescribing for acute respiratory infections, 1995-2000. Data from the UK General Practice Research Database, J Clin Pharm Ther, vol. 31, pp. 461-7, 2006.
J. Assayag, Pollak, M. N., and Azoulay, L., The use of aspirin and the risk of mortality in patients with prostate cancer, J Urol, vol. 193, pp. 1220-5, 2015.
J. Assayag, Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., and Azoulay, L., Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer, Cancer Causes Control, vol. 24, pp. 839-45, 2013.
J. L. Atkins, Delgado, J., Pilling, L. C., Bowman, K., Masoli, J. A. H., Kuchel, G. A., Ferrucci, L., and Melzer, D., Impact of Low Cardiovascular Risk Profiles on Geriatric Outcomes: Evidence From 421,000 Participants in Two Cohorts, J Gerontol A Biol Sci Med Sci, 2018.
R. W. Atkinson, Carey, I. M., Kent, A. J., van Staa, T. P., Anderson, H. R., and Cook, D. G., Long-term exposure to outdoor air pollution and the incidence of chronic obstructive pulmonary disease in a national English cohort, Occup Environ Med, vol. 72, pp. 42-8, 2015.
R. W. Atkinson, Carey, I. M., Kent, A. J., van Staa, T. P., Anderson, H. R., and Cook, D. G., Long-term exposure to outdoor air pollution and incidence of cardiovascular diseases, Epidemiology, vol. 24, pp. 44-53, 2013.
E. L. Axson, Bloom, C. I., and Quint, J. K., Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016, Eur J Clin Microbiol Infect Dis, vol. 37, pp. 1795-1803, 2018.
E. L. Axson, Bual, N., Bloom, C. I., and Quint, J. K., Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK, Eur J Clin Microbiol Infect Dis, 2018.
E. L. Axson, Sundaram, V., Bloom, C. I., Bottle, A., Cowie, M. R., and Quint, J. K., Temporal Trends in the Incidence of Heart Failure among Patients with COPD and Its Association with Mortality, Ann Am Thorac Soc, 2020.
H. T. Ayele, Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., and Filion, K. B., Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study, World J Urol, 2020.
L. Azoulay, Eberg, M., Benayoun, S., and Pollak, M., 5alpha-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer, JAMA Oncol, vol. 1, pp. 314-20, 2015.
L. Azoulay, Dell'Aniello, S., Simon, T. A., Renoux, C., and Suissa, S., Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes, Eur Heart J, vol. 35, pp. 1881-7, 2014.
L. Azoulay, Schneider-Lindner, V., Dell'Aniello, S., Filion, K. B., and Suissa, S., Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study, Pharmacoepidemiol Drug Saf, vol. 19, pp. 343-50, 2010.
L. Azoulay, Dell'Aniello, S., Simon, T. A., Langleben, D., Renoux, C., and Suissa, S., A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
L. Azoulay, Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., and Suissa, S., The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study, Bmj, vol. 344, p. e3645, 2012.
L. Azoulay, Dell'Aniello, S., Simon, T., Renoux, C., and Suissa, S., The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation, Thromb Haemost, vol. 109, pp. 431-9, 2013.
L. Azoulay, Soldera, S., Yin, H., and Bouganim, N., Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study, Epidemiology, vol. 27, pp. 594-601, 2016.
L. Azoulay, Schneider-Lindner, V., Dell'Aniello, S., Schiffrin, A., and Suissa, S., Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
L. Azoulay, Dell'Aniello, S., Gagnon, B., Pollak, M., and Suissa, S., Metformin and the incidence of prostate cancer in patients with type 2 diabetes, Cancer Epidemiol Biomarkers Prev, vol. 20, pp. 337-44, 2011.
L. Azoulay, Dell'Aniello, S., Huiart, L., Fort, G. G. du, and Suissa, S., Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
L. Azoulay, Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., and Suissa, S., Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer, Eur Urol, vol. 60, pp. 1244-50, 2011.
L. Azoulay, Yin, H., Renoux, C., and Suissa, S., The use of atypical antipsychotics and the risk of breast cancer, Breast Cancer Res Treat, vol. 129, pp. 541-8, 2011.
L. Azoulay, Assimes, T. L., Yin, H., Bartels, D. B., Schiffrin, E. L., and Suissa, S., Long-term use of angiotensin receptor blockers and the risk of cancer, PLoS One, vol. 7, p. e50893, 2012.
B
E. Badrick, Renehan, I., and Renehan, A. G., Linkage of the UK Clinical Practice Research Datalink with the national cancer registry, Eur J Epidemiol, 2018.
S. E. Bailey, Ukoumunne, O. C., Shephard, E. A., and Hamilton, W., Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data, Br J Gen Pract, vol. 67, pp. e405-e413, 2017.
K. Bailey, Ellis, C., and Majeed, A., Trends in the treatment of osteoporosis and types of drug treatments prescribed in general practice in England and Wales, 1994 to 1998, Health Stat Q, pp. 5-13, 2002.
A. Baker, Chen, L. C., Elliott, R. A., and Godman, B., The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental desi, BMC Health Serv Res, vol. 15, p. 367, 2015.
R. Baker, Orton, E., Tata, L. J., and Kendrick, D., Epidemiology of poisonings, fractures and burns among 0-24 year olds in England using linked health and mortality data, Eur J Public Health, vol. 26, pp. 940-946, 2016.
R. Baker, Tata, L. J., Kendrick, D., Burch, T., Kennedy, M., and Orton, E., Differing patterns in thermal injury incidence and hospitalisations among 0-4 year old children from England, Burns, vol. 42, pp. 1609-1616, 2016.
R. Baker, Kendrick, D., Tata, L. J., and Orton, E., Association between maternal depression and anxiety episodes and rates of childhood injuries: a cohort study from England, Inj Prev, vol. 23, pp. 396-402, 2017.
R. Baker, Tata, L. J., Kendrick, D., and Orton, E., Identification of incident poisoning, fracture and burn events using linked primary care, secondary care and mortality data from England: implications for research and surveillance, Inj Prev, vol. 22, pp. 59-67, 2016.
A. Bakhai, Rigney, U., Hollis, S., and Emmas, C., Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population, Pharmacoepidemiol Drug Saf, vol. 21, pp. 485-93, 2012.
A. Bakhai, Petri, H., Vahidnia, F., Wolf, C., Ding, Y., Foskett, N., and Sculpher, M., Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England, J Eval Clin Pract, 2020.
V. Balinskaite, Bou-Antoun, S., Johnson, A. P., Holmes, A., and Aylin, P., An assessment of potential unintended consequences following a national antimicrobial stewardship programme in England: an interrupted time series analysis, Clin Infect Dis, 2018.
L. Ban, Sprigg, N., A. Sultan, A., Nelson-Piercy, C., Bath, P. M., Ludvigsson, J. F., Stephansson, O., and Tata, L. J., Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population-Based Cohort Study From England, J Am Heart Assoc, vol. 6, 2017.
A. Banerjee, Chen, S., Pasea, L., Lai, A. G., Katsoulis, M., Denaxas, S., Nafilyan, V., Williams, B., Wong, W. K., Bakhai, A., Khunti, K., Pillay, D., Noursadeghi, M., Wu, H., Pareek, N., Bromage, D., McDonagh, T. A., Byrne, J., Teo, J. T. H., Shah, A. M., Humberstone, B., Tang, L. V., Shah, A. S. V., Rubboli, A., Guo, Y., Hu, Y., Sudlow, C. L. M., Lip, G. Y. H., and Hemingway, H., Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic, Eur J Prev Cardiol, 2021.
A. Banerjee, Allan, V., Denaxas, S., Shah, A., Kotecha, D., Lambiase, P. D., Jacob, J., Lund, L. H., and Hemingway, H., Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis, Europace, 2019.
A. Banerjee, Pasea, L., Harris, S., Gonzalez-Izquierdo, A., Torralbo, A., Shallcross, L., Noursadeghi, M., Pillay, D., Sebire, N., Holmes, C., Pagel, C., Wong, W. K., Langenberg, C., Williams, B., Denaxas, S., and Hemingway, H., Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study, Lancet, vol. 395, pp. 1715-1725, 2020.
C. A. Bannister, Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., Mukherjee, J., and Currie, C. J., Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls, Diabetes Obes Metab, vol. 16, pp. 1165-73, 2014.
C. A. Bannister, Poole, C. D., Jenkins-Jones, S., Morgan, C. L., Elwyn, G., Spasic, I., and Currie, C. J., External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations, Diabetes Care, vol. 37, pp. 537-45, 2014.
F. J. Bannon, O'Rorke, M. A., Murray, L. J., Hughes, C. M., Gavin, A. T., Fleming, S. J., and Cardwell, C. R., Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink, Cancer Causes Control, vol. 24, pp. 2027-34, 2013.
M. F. Barakat, McDonald, H. I., Collier, T. J., Smeeth, L., Nitsch, D., and Quint, J. K., Acute kidney injury in stable COPD and at exacerbation, Int J Chron Obstruct Pulmon Dis, vol. 10, pp. 2067-77, 2015.
L. Baril, Rosillon, D., Willame, C., Angelo, M. G., Zima, J., van den Bosch, J. H., Van Staa, T., Boggon, R., Bunge, E. M., Hernandez-Diaz, S., and Chambers, C. D., Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom, Vaccine, vol. 33, pp. 6884-91, 2015.
I. Barker, Lloyd, T., and Steventon, A., Effect of a national requirement to introduce named accountable general practitioners for patients aged 75 or older in England: regression discontinuity analysis of general practice utilisation and continuity of care, BMJ Open, vol. 6, p. e011422, 2016.
I. Barker, Steventon, A., and Deeny, S. R., Association between continuity of care in general practice and hospital admissions for ambulatory care sensitive conditions: cross sectional study of routinely collected, person level data, Bmj, vol. 356, p. j84, 2017.
S. Bartholomeeusen, Van Zundert, J., Truyers, C., Buntinx, F., and Paulus, D., Higher incidence of common diagnoses in patients with low back pain in primary care, Pain Pract, vol. 12, pp. 1-6, 2012.
J. N. Bashford, Norwood, J., and Chapman, S. R., Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database, Bmj, vol. 317, pp. 452-6, 1998.
V. Baskaran, Pearce, F., Harwood, R. H., McKeever, T. M., and Lim, W. S., Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study, Br J Gen Pract, vol. 71, pp. e250-e257, 2021.
H. Batchelor, Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: a retrospective database review, Eur J Pharm Biopharm, 2020.
G. Baxter, Morgan, C. L., Jenkins-Jones, S., Currie, C. J., and Schultewolter, D., Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study, Value Health, vol. 18, p. A658, 2015.
[Page last reviewed 6 April 2021]